Devimistat New

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP04663CAS No. ：95809-78-2Purity：98%

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	95809-78-2	Cat. No.	BCP04663
Name	Devimistat
Synonyms	CPI 613;CPI613;CPI-613;
SMILES	O=C(O)CCCCC(SCC1=CC=CC=C1)CCSCC2=CC=CC=C2
Chemical Name
Formula	C22H28O2S2	M. Wt	388.59
Purity	98%	Storage	Store at 4-8°C
Description	Devimistat, also known as CPI-613, is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, alpha-lipoic acid analogue CPI-613 has been shown to inhibit metabolic and regulatory processes required for cell growth in solid tumors. Both enantiomers in the racemic mixture exhibit antineoplastic activity. The mechanism-of-action of CPI-613 appears distinct from the current classes of anti-cancer agents used in the clinic. CPI-613 demonstrates both in vitro and in vivo anti-tumor activity. CPI-613 was known to strongly disrupt tumor mitochondrial metabolism.